Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofacitinib effects on coagulation and platelet function in ulcerative colitis
2021-002211-65Phase 4Active
- Sponsor
- Fundación Española de Gastroenterología
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tofacitinib in autoimmune colitis (2 arms), sponsored by Fundación Española de Gastroenterología. Primary endpoint: Platelet function and clot formation kinetics. Started Jun 2021; status: active.
02
Drugs
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2021-002211-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-002211-65.